| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/04/2007 | CN1308021C Antivirus oral liquid |
| 04/04/2007 | CN1308017C Medicine composition for treating diarrhea, dysentery and eruptive disease |
| 04/04/2007 | CN1308011C Method for extracting ganoderma lucidum spore fat soluble active substance |
| 04/04/2007 | CN1308010C Method for extracting active component of radix scutellariae |
| 04/04/2007 | CN1307971C Antimycotic nail varnish composition |
| 04/04/2007 | CN1307917C Bactericidal skin lotion transparent gloves containing chitin salt |
| 04/04/2007 | CN1307881C New use of bactericide H4Ag 206 containing silver and its prepared medicine |
| 04/03/2007 | US7199215 Pseudopeptide, synthesis method, reagent and applications |
| 04/03/2007 | US7199162 Pretreatment before allogenic transplantation of bone marrow or haematopoietic stem cells; may be administered with other chemotherapeutic or immunosuppressive agents; antitumor and anticarcinogenic agents |
| 04/03/2007 | US7199152 TNF-α production inhibitor comprising kavalactone as an active ingredient |
| 04/03/2007 | US7199150 Amino alcohol compounds |
| 04/03/2007 | US7199148 Such as (1-Benzyl-2-hydroxy-3-{isobutyl-[2-oxo-3-(1H-pyrrol-2-ylmethylene)-2,3-dihydro-1H-indole-5-sulfonyl]-amino}-propyl)-carbamic acid hexahydro-furo[2,3-b]furan-3-yl ester; multi-drug resistant HIV infections |
| 04/03/2007 | US7199147 Rho kinase inhibitors |
| 04/03/2007 | US7199145 Derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments |
| 04/03/2007 | US7199143 3-[4-(3,6-dihydro-2H-thiopyran-4-yl) phenyl]-]5[1H or 2H-1,2,3-triazol-1 or 2-yl] oxazolidin-2-ones; grampositive bactericides for drug resistant bacteria, especially Staphylococcus, Enterococcus, and Streptococcus |
| 04/03/2007 | US7199142 1-((5-aryl-1,2,4-oxadiazol-3-yl) benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl) pyrrolidine-3-carboxylates as edg receptor agonists |
| 04/03/2007 | US7199128 8-N-substituted-2H-isothiazolo[5,4-b]quinolizine-3,4-diones and related compounds as antiinfective agents |
| 04/03/2007 | US7199121 Protein tyrosine phosphatase inhibitor |
| 04/03/2007 | US7199120 Pyrazolo-pyridine derivatives as antiherpes agents |
| 04/03/2007 | US7199114 Triterpene quaternary salts as biologically active surfactants |
| 04/03/2007 | US7198944 for the treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, wound healing and psoriasis |
| 04/03/2007 | US7198934 Genetic engineering; gene insertion; culture product |
| 04/03/2007 | US7198922 Synthesizing polyketide fusion protein comprising acyltransferase domain for use as anthelminthic, insecticide, antitumor, immunosuppressant, fungicidal and/or bactericidal agents |
| 04/03/2007 | US7198913 Nucleotide sequences coding polypeptide for use in the treatment of apoptosis, inflammatory and autoimmune disorders |
| 04/03/2007 | US7198910 Nucleic acid encoding melanin-concentrating hormone receptor |
| 04/03/2007 | US7198892 Hepatitis-C virus type 4, 5 and 6 |
| 04/03/2007 | US7198800 spray on skin patch drug delivery system; substantially water insoluble film forming agent; film plasticiser agent; water soluble compound; and organic solvent |
| 04/03/2007 | US7198796 Antifungal parenteral products |
| 04/03/2007 | US7198254 System for producing micro-cluster liquids |
| 04/03/2007 | CA2419573C Method of increasing testosterone and related steroid concentrations in women |
| 04/03/2007 | CA2193365C Polynucleotide vaccine for papillomavirus |
| 04/03/2007 | CA2162397C Ligands for flt3 receptors |
| 04/03/2007 | CA2121559C Immunogenic artificial polypeptide |
| 04/03/2007 | CA2066384C Gastrointestinal mucosa-adherent matrixes, pharmaceutical preparation and a coating composition |
| 03/29/2007 | WO2007035911A1 System and method for the prevention and treatment of bacterial and fungal infections including urinary tract infections (uti) using a hypohalous acid compositions |
| 03/29/2007 | WO2007034948A1 Method of inhibiting the proliferation and migration of helicobacter pylori |
| 03/29/2007 | WO2007034927A1 Medicine, food and drink or feed containing sphingomyelin |
| 03/29/2007 | WO2007034924A1 METALLO-β-LACTAMASE INHIBITOR |
| 03/29/2007 | WO2007034917A1 Novel adenine compound |
| 03/29/2007 | WO2007034916A1 Novel adenine compound |
| 03/29/2007 | WO2007034882A1 Novel adenine compound |
| 03/29/2007 | WO2007034881A1 Novel adenine compound |
| 03/29/2007 | WO2007034817A1 Novel adenine compound |
| 03/29/2007 | WO2007034748A1 Immunomodulating agent in gut |
| 03/29/2007 | WO2007034742A1 Method of treating virus-infected biological substance and cell, tissue and organ having been subjected to treatment against infecting virus |
| 03/29/2007 | WO2007034741A1 Anti-viral agent, and method for treatment of virus-infected cell |
| 03/29/2007 | WO2007034678A1 Novel antifungal agent |
| 03/29/2007 | WO2007034627A1 Additive for animal feed |
| 03/29/2007 | WO2007034262A1 Heterodimeric meganucleases and use thereof |
| 03/29/2007 | WO2007034173A1 Purine derivatives for the treatment of viral or allergic diseases and cancers |
| 03/29/2007 | WO2007034166A2 Adjuvanted vaccine |
| 03/29/2007 | WO2007034127A1 Benzodiazepine derivatives for treating hepatitis c infection |
| 03/29/2007 | WO2007034022A1 Composition for administration to mammals or humans |
| 03/29/2007 | WO2007033533A1 Use of nocardia rubra cell wall skeleton to produce medicaments for resisting human papilloma virus hpv |
| 03/29/2007 | WO2007033529A1 A gene encoding antibacterial protein of fenneropenaeus chinensis and its recombination expression method and uses |
| 03/29/2007 | WO2007033522A1 Capsule formulation containing moxifloxacin and its preparation method |
| 03/29/2007 | WO2007033515A1 Oral formulation containing moxifloxacin and its preparation method |
| 03/29/2007 | WO2007033419A1 Composition and method for inhibiting herpesviridae infections |
| 03/29/2007 | WO2007016589A3 Inhibitors of serine proteases |
| 03/29/2007 | WO2007015809A3 Hiv reverse transcriptase inhibitors |
| 03/29/2007 | WO2007014941A3 Quinoline derivatives as antibacterial agents |
| 03/29/2007 | WO2007014940A3 Quinoline derivatives as antibacterical agents |
| 03/29/2007 | WO2007014940A2 Quinoline derivatives as antibacterical agents |
| 03/29/2007 | WO2007000591A3 Antimicrobial materials |
| 03/29/2007 | WO2006134423A3 Methods and compositions for inducing innate immune responses |
| 03/29/2007 | WO2006130501A3 Tigecycline and methods of preparing 9-nitrominocycline |
| 03/29/2007 | WO2006120705A3 Treatment and control of severe infections including cystic fibrosis |
| 03/29/2007 | WO2006112714A3 Uronic acid and probiotics |
| 03/29/2007 | WO2006110881A3 Yersinia polypeptide vaccines, antibodies and immunomodulatory proteins |
| 03/29/2007 | WO2006107655A3 Use of wnv dna vaccine in combination with a conventional vaccine to overcome immunogen interference |
| 03/29/2007 | WO2006099325A3 Methods of treating ear infections |
| 03/29/2007 | WO2006072625A8 Anti-kir combination treatments and methods |
| 03/29/2007 | WO2002056916A8 Compositions and methods for enhanced pharmacological activity through oral and parenteral administration of compositions comprising polypeptide drug substances and other poorly absorbed active ingredients |
| 03/29/2007 | US20070072945 Sulphur-containing oils for controlling plant pathogens and stimulating nutrient uptake |
| 03/29/2007 | US20070072916 Amino ceramide-like compounds and therapeutic methods of use |
| 03/29/2007 | US20070072911 Indoles and azaindoles as antiviral agents |
| 03/29/2007 | US20070072835 Method of preparing and use of prodrugs of betulinic acid derivatives |
| 03/29/2007 | US20070072811 like antiinfective (bactericide, fungicide, parasiticide, viricide), and antiproliferative, antiinflammatory, and prokinetic agents; 1,2,3-triazole-oxazolidine-phenyl- derivatives; effective against strains of cells or organisms that have developed drug resistance; administering orally |
| 03/29/2007 | US20070072805 Fusion peptide-induced hemolysis effectively inhibited by peptides of the invention compared to virus-inhibitory peptide (VIRIP); peptide blocks cellular infection by HIV particles by interacting with the fusion peptide of HIV viral glycoprotein 41 (gp41) to prevent virus entry into thecell |
| 03/29/2007 | US20070072236 Novel type II Na/Pi cotransporters and type II Na/Pi cotransporter expression regulatory factors |
| 03/29/2007 | US20070072198 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 03/29/2007 | US20070071774 Protein D - an IgD-binding protein of Haemophilus influenzae |
| 03/29/2007 | US20070071770 Recombinant MVA virus, and the use thereof |
| 03/29/2007 | US20070071769 Recombinant MVA virus, and the use thereof |
| 03/29/2007 | US20070071752 Sphingosine kinase enzyme |
| 03/29/2007 | US20070071742 bind ICAM-1 and inhibit pathogen infection of cells expressing ICAM-1; for protection against human rhinovirus (HRV), coxackie A virus, respiratory syncytial virus (RSV), or malaria |
| 03/29/2007 | US20070069416 Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
| 03/29/2007 | DE102005045146A1 Antimicrobial preparation useful for treating e.g. wound, eczema and vaginal infections comprises octenidine dihydrochloride encapsulated in liposomes |
| 03/29/2007 | CA2623576A1 System and method for the prevention and treatment of bacterial and fungal infections including urinary tract infections (uti) using a hypohalous acid compositions |
| 03/29/2007 | CA2623351A1 Antiviral therapy with carbohydrate binding agents |
| 03/29/2007 | CA2623304A1 Medicine, food and drink or feed containing sphingomyelin |
| 03/29/2007 | CA2622997A1 A liposome composition to cause lysis of cells and pathogens |
| 03/29/2007 | CA2622592A1 Benzodiazepine derivatives for treating hepatitis c infection |
| 03/29/2007 | CA2620675A1 Metallo-.beta.-lactamase inhibitors |
| 03/28/2007 | EP1767641A1 Antigenic neisserial peptides |
| 03/28/2007 | EP1767542A2 HLA-A2. 1 binding peptides and their uses |
| 03/28/2007 | EP1767536A1 Quinolone carboxylic acid derivatives, thereof preparation and usage |
| 03/28/2007 | EP1767526A1 Novel arylamidine derivative, salt thereof, and antifungal containing these |
| 03/28/2007 | EP1767097A2 Green tea extracts |
| 03/28/2007 | EP1766093A2 Antibodies against clostridium difficile toxins and uses thereof |